Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duobrii in palmoplantar plaque psoriasis
NCT04720105Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Nov 2020
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of halobetasol propionate + tazarotene in palmoplantar plaque psoriasis (PPP), sponsored by Icahn School of Medicine at Mount Sinai. Started Nov 2020; status: completed.
02
Drugs
halobetasol propionate + tazarotene
03
Conditions
palmoplantar plaque psoriasis (PPP)
Beyond the preview
Go deeper on NCT04720105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04720105.